Given the challenges in directly targeting the “undruggable” c‐Myc protein structure,[44] our study highlights the potential of targeting SQLE as a novel, practical, and innovative approach for inhibiting c‐Myc activity in cancer treatment, thus emphasizing the significance of our findings in the field of cancer therapeutics. This evidence concerns the gene MYC and cancer.